Novo Nordisk Insulin Revenue Drives 1Q Profits

May 1 (Bloomberg) -- Bloomberg Europe business correspondent Caroline Hyde reports that Novo Nordisk A/S announced a 28 percent increase in first-quarter profit as sales climbed for its insulins and the Victoza diabetes treatment. She speaks on Bloomberg Television's "The Pulse."
Square Rival iZettle Raises $67M From Intel and Zouk
39:11 - Today’s "BWest Byte" is $67 million, for how much iZettle, a Swedish payments startup and rival to Jack Dorsey's Square, has raised from Intel and Zouk. Bloomberg's Matt Miller reports on "Bloomberg West." (Source: Bloomberg)
  • What's Next for Flexible Electronic Technology?
  • Facebook Cracks Down on Video Pirates
  • Deep Dive: Is Market Turmoil Hurting Consumer Sentiment?